最終更新日: 8月 25, 2026
Prostate cancer is among the commonest cancers in men, and for decades the way of confirming it was the same: a needle passed through the wall of the rectum, sampling the prostate in a fixed pattern without knowing where any cancer actually was. Two things have changed since. They are separate changes, and they are constantly confused with one another — including in the earlier version of this article.
- 泌尿器センター バンコク病院 タイ オンライン予約 02-310-3009 bhquro@bdms.co.th
- サミティジ・シラチャ病院 チョンブリ 088-022-1445
Two advances, doing two different jobs
- MRI targeting changes what the biopsy finds. An MRI is performed first and scored for suspicious areas. Those images are then fused with the live ultrasound during the procedure, so the needle goes to the suspicious area rather than sampling blindly. This finds more of the cancers that matter, and finds fewer of the trivial ones that would never have caused harm.
- The transperineal route changes how safe the biopsy is. The needle passes through the skin between the scrotum and the anus instead of through the rectal wall, so it does not carry bowel bacteria into the prostate and bloodstream.
They are independent. A transrectal biopsy can be MRI-targeted, and a transperineal biopsy can be done without MRI. Doing both together is the current standard, but the credit belongs where it is due.


A correction to the comparison table published here
The earlier version of this article set out a table comparing the MRI-fusion transperineal approach against the conventional transrectal approach, giving cancer detection of 81% against 40%. That comparison has been removed, for two reasons.
First, the two columns differed in two ways at once — the route そして whether MRI targeting was used — so no row in the table could be attributed to either one. Second, the two figures came from two different studies of different groups of men using different definitions, and setting them side by side implied a head-to-head comparison that was never made.
What the better evidence shows is more specific, and more useful:
- MRI targeting genuinely improves detection of clinically significant cancer compared with untargeted sampling — that gain is real and it is why MRI is now done before biopsy rather than after.
- Route makes little difference to detection. Randomised trials comparing transperineal against transrectal biopsy have found broadly similar cancer detection. Choosing the transperineal route is not how you find more cancer.
- Route makes a large difference to infection, which is the honest case for it, and a strong one.
The figure of 0% for prostatitis in the old table has also gone. No procedure has a zero complication rate, and publishing one invites a confidence the numbers cannot support.
What the route actually buys you
| Transperineal | Transrectal |
| Needle through the skin of the perineum | Needle through the rectal wall |
| Serious bloodstream infection is uncommon | Serious bloodstream infection is a recognised and more frequent risk, and antibiotic resistance has been making it worse |
| Rectal bleeding essentially avoided | Rectal bleeding common, occasionally significant |
| Better access to the front part of the gland, which transrectal sampling reaches poorly | Anterior tumours are more easily missed |
| Perineal soreness and bruising for a few days | Less perineal discomfort |
| Blood in the urine and semen for days to weeks | Blood in the urine and semen for days to weeks |
Blood in the semen deserves a word of its own because it alarms men who were not warned: it is expected, it can look dramatic, and it can persist for several weeks. It is not a sign that anything has gone wrong.
The MRI comes first — and may spare you the biopsy
This is worth knowing before you agree to anything. The modern sequence is MRI first, biopsy second, and the scan is scored for how suspicious it looks.
Where the MRI shows nothing suspicious and the clinical picture is reassuring, it is often reasonable not to biopsy at all, and instead to follow the PSA. Men are frequently unaware this option exists. Where the MRI shows a suspicious area, the biopsy targets it — and usually takes some additional systematic samples as well, because MRI does not see everything.
Whether to have a PSA test in the first place is its own decision, discussed under should I have a PSA test.
What a biopsy cannot tell you
- A negative biopsy does not prove there is no cancer. It samples a fraction of the gland. If the PSA continues rising or the MRI remains suspicious, the question stays open.
- A positive biopsy does not always mean treatment. Some prostate cancers found this way grow so slowly that monitoring is the correct management and treating them would cause more harm than the disease. Finding cancer and needing surgery are not the same thing.
- The grade matters more than the fact. What the pathologist reports about how aggressive the cells look drives everything that follows.
If the biopsy does confirm cancer, the next conversation is about treatment — see the surgical treatment options, including robotic prostatectomy and how candidates are selected.
Symptoms after a biopsy that need attention the same day
Infection after prostate biopsy can become serious quickly. In an emergency in Thailand, call 1669.
- 発熱または寒気と震え — go to hospital, do not wait until morning. This is the one that matters most.
- Feeling faint, confused, or profoundly unwell.
- Inability to pass urine with a painful full bladder.
- Heavy bleeding, or clots blocking the flow.
- Increasing perineal pain and swelling after the first couple of days rather than settling.
お客様からよくいただくご質問
What is an MRI-fusion transperineal prostate biopsy?
An MRI performed beforehand is fused with the live ultrasound image during the procedure, so the needle is directed at the suspicious area rather than sampling blindly. The needle passes through the skin of the perineum rather than through the rectal wall. The first part improves what is found; the second part reduces infection.
Does the transperineal route find more cancer?
Not by itself. Randomised comparisons have found broadly similar detection between the two routes. What improves detection is MRI targeting, which can be used with either route. An earlier version of this article implied the route was responsible for a large detection advantage, and that has been corrected.
Why choose transperineal then?
Because it avoids driving bowel bacteria into the prostate and bloodstream. Serious infection after transrectal biopsy is uncommon but real, and antibiotic resistance has made it harder to prevent. Transperineal biopsy also reaches the front of the gland better, where transrectal sampling is weakest.
Is it painful, and will I be asleep?
It can be done under local anaesthetic or under general or spinal anaesthesia, depending on the number of samples planned, your anatomy and your preference. Ask which is planned for you before the day. Afterwards, expect perineal soreness and bruising for a few days.
My MRI was normal. Do I still need a biopsy?
Often not. Where the MRI shows nothing suspicious and the clinical picture is reassuring, following the PSA rather than proceeding to biopsy is frequently a reasonable option. It is a decision to make deliberately with your urologist rather than assuming the biopsy is automatic.
If cancer is found, will I need surgery?
Not necessarily. Some prostate cancers grow slowly enough that active monitoring is the right management and treatment would do more harm than the disease. The grade reported by the pathologist, not the mere presence of cancer, determines what happens next.
Is this available in Bangkok?
Yes. Dr. Soarawee Weerasopone performs MRI-fusion transperineal prostate biopsy at Bangkok Hospital Headquarters.
相談の手続きをする
Dr. Soarawee Weerasopone sees patients at バンコク病院本部 そしてチョンブリー県のサミティベート・シーラチャ病院にて 088-022-1445. Bring every previous PSA result with its date, and the MRI images themselves rather than only the report.
バンコク病院の遠隔医療は、来院が困難な患者様(海外からの患者様を含みます)を対象にご利用いただけます。泌尿器科宛てに事前にメールでご手配ください。 bhquro@bdms.co.th. サミティベート・シラチャは対面診療のみです。料金に関するお問い合わせは当ウェブサイトではなく、病院にお問い合わせください。.
免責事項 この記事の内容は、バンコク病院本社(Bangkok Hospital Headquarters)の認定泌尿器科医であるソラウィー・ウィーラソポン医師(Dr. Soarawee Weerasopone)が執筆および監修したものであり、教育目的のみを意図しています。これは医学的なアドバイス、診断、または個別の処方ではなく、個人的なメッセージングチャンネルやソーシャルメディアを通じてアドバイス、診断、処方が行われることはありません。ソラウィー医師は公開のソーシャルメディアアカウントを運営していません。彼の名前で個人的な相談を提供しているアカウントはすべて詐欺です。タイで緊急事態が発生した場合は、以下にお電話ください。 1669.
医学的に記述・監修: ソアラウィー・ウィーラソポーン医師(ポム医師)— 認定泌尿器科医、バンコク病院本部、2016年より泌尿器科診療に従事。フェローシップ:ロボット手術、長庚記念病院、台湾(2019年) · オブザーバーシップ:内視鏡泌尿器科、順天堂大学病院、東京(2022年) · 研究員兼臨床オブザーバー、ベイラー医科大学スコット泌尿器科、米国(2025年~2026年)。.

ソアラウィー・ウィーラソポーン医師(愛称:ポム医師)は、バンコク病院本院の認定泌尿器科医であり、男性医学、ロボット支援手術(ダヴィンチXi)、および尿路結石治療を専門としています。現在、モヒット・ケラ教授の指導の下、ベイラー医科大学スコット泌尿器科の客員研究員および臨床オブザーバーを務めています(2025〜20記念6年)。2019年に台湾の長庚紀念病院でロボット手術のフェローシップを修了し、2022年には東京の順天堂大学病院で内視鏡泌尿器科のオブザーバーシップを修了しました。.

